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Summ_uxy A point mutation in the mRNA of NADP(H): quinone oxidoreductase 1 (NQOI, DT-diaphorase)
is believed to be responsible for reduced enzyme activity in the adenocarcinoma BE cell line. The present study
examined nine cultured human non-cancerous fibroblast cell strains, five of which were from members of a
single cancer-prone family, which demonstrated widely varying activity levels of DT-diaphorase
(41-3462 nmol min-'mg-' protein), to determine if genetic alteration of the NQOI or NOQ2 gene was
involved in determining enzyme activity. All cell strains expressed NQOI and NQO. mRNA as measured by a
quantitative polymerase chain reaction amplification technique. No relationship was found between the level
of mRNA expressed and the enzyme activity in the cells. Sequencing of the entire complementary DNA from
the cell strains revealed only a single base substitution at nucleotide 609 in one allele encoding NQOI in every
cell strain from members of the cancer-prone family, except for one cell strain which expressed only the T at
nucleotide 609 in both alleles. Subsequent examination of genomic DNA from 44 individuals revealed that this
base substitution is present in approximately 50%0 of the population. The presence of the T at nucleotide 609
in the NQOI locus does not appear to be directly causal for altered DT-diaphorase activity.
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DT-diaphorase is a two-electron-reducing flavoenzyme which
catalyses the oxidation of NADH or NADPH (Ernster,
1987). It belongs to the family of phase II detoxification
enzymes. which includes glutathione S-transferase and
glutathione peroxidase along with other transferases and
reductases (Nebert. 1994). This enzyme family is responsible
for diverting potentially reactive electrophiles from damaging
interactions with the nucleophilic groups of DNA and
ultimately functions to protect tissue against carcinogenic
and mutagenic compounds (Talalay and Benson, 1982). Two-
electron reduction bypasses the formation of the semi-
quinone, which in the presence of oxygen can be efficiently
back-oxidised, leading to the production of active oxygen
species (Lind et al.. 1982; Thor et al., 1982; Fisher et al.,
1992. 1993). Once quinone-containing compounds form the
semiquinone or hydroquinone a rearrangement may occur.
producing an active alkylating species (Tomasz et al.,
1988a.b).
Two NAD(P)H:quinone oxidoreductase isozymes were first
identified in human liver. NQO1 and NQO2 (Jaiswal et al..
1988, 1990). NQO, is expressed in all tissues while NQO2 is
only expressed in heart, lung, liver, brain and skeletal muscle
(Jaiswal. 1994). NQOI is an inducible homodimenrc enzyme
in the active state. NQOI is believed to mediate most cellular
quinone reduction since quinone-containing compounds are
good substrates for purified human NQO, (Gibson et al.,
1992; Siegel et al., 1992; Ross et al., 1993). NQO2 also
appears to be an inducible enzyme which is 54% similar to
NQOI at the cDNA level (Jaiswal et al., 1990; Jaiswal, 1994).
The function of NQO. has not yet been determined, although
it is known that NQO2 is less effective at reducing certain
quinone-containing compounds than NQOI (Jaiswal et al.,
1990; Jaiswal, 1994). The physiological role of each form still
remains uncertain (Belinsky and Jaiswal, 1993). Diaphorase
activity coded by independent gene loci and with distinct
biochemical characteristics has been identified in most cell
types, including red blood cells and sperm. Only NQOI (also
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known as DT-diaphorase and diaphorase4) and NQO2 are
able to utilise either NADPH or NADH as co-factor (Fisher
et al., 1977; Jaiswal, 1990; Belinsky and Jaiswal, 1993).
NQOI is known to be induced by several procarcinogens,
and a perturbation in the expression of this enzyme might
occur during carcinogenesis. Increased levels of NQO, gene
expression have been observed in liver, lung and colon
tumours, as well as in premalignant growths. indicating that
this enzyme may have a role to play either in the car-
cinogenic process or in cellular defence mechanisms during
tumour initiation (Cresteil and Jaiswal, 1991; Riley and
Workman, 1992). It is possible that a deficiency in NQO,
may decrease the ability of the cell to detoxify carcinogens,
thereby affecting cellular metabolic pathways and increasing
the carcinogenic burden, and perhaps predisposing the
affected individual to malignant disease.
Studies by Marshall et al. (1991) demonstrated a relation-
ship between reduced DT-diaphorase activity and enhanced
resistance of some cultured human fibroblast cell strains to
mitomycin C (MMC), a quinone-contaiing, bioreductive
DNA-alkylating chemotherapeutic agent (Lin et al., 1976;
Sartorelli, 1988). These DT-diaphorase-deficient cell strains
were derived from members of a cancer-prone family, some
of whom had developed malignancies (Fraumeni et al., 1.968).
Further studies by Marshall et al. (1991) and Traver et al.
(1992) revealed that NQO, protein could not be detected by
Western analysis in cell strains/lines which have a very low
level of DT-diaphorase activity using a polyclonal antibody
against rat DT-diaphorase, even though mRNA was exp-
ressed and detected by Northern blot analysis or quantitative
PCR. Traver's group, using two human adenocarcinoma cell
lines, HT-29 and BE, with high and low DT-diaphorase
activities respectively, found a missense mutation in the
mRNA of the BE cell line at nucleotide 609, which is a
predicted proline to serine change at this residue. They con-
cluded that this missense mutation may alter the secondary
structure of the enzyme and thus decrease enzyme activity
without affecting mRNA synthesis (Traver et al., 1992).
The present work has extended the earlier studies of Mar-
shall et al. (1991) and examined nine cultured human non-
cancerous fibroblast cell strains with varying levels of DT-
diaphorase activity, five of which were derived from a single
cancer-prone family. Studying human fibroblast cell strainsBase aleation and DT-diaphorase actvity
BL Kuehl et a)
556
of cancer-prone families may allow- genetic and biochemical
changes to be detected which predispose individuals to cancer
(Paterson et al.. 1986). The cell strains were assessed for
expression of both NQO1 and NQO2 and the possible
presence of a genetic alteration which might decrease the
enzymatic activity of NQOI. and perhaps be a link to the
increased susceptibility to cancer noted in this familv. The
presence of an alteration in those cell strains with low-
enzyme activitv would provide further evidence for the
importance of the fidelity of the gene in maintaining
enzy-matic activity. The results reveal that all cell strains
examined express both NQOI and NQO2 mRNA. Further-
more. the base substitution at nucleotide 609 is present in
approximately 50%0 of the normal population. While this
base substitution is present in all of the cell strains from
members of the cancer-prone family. it does not appear to
have a direct effect on DT-diaphorase activity.
Table I Clinical status and patient relationship information
Cell
strain
3437T
3'01T
3702T
3703T
3704T
GM38
GM730A
3424T
2800T
Clinical status
otf donor
Glioblastoma
AN-L
Endometnal
carcinoma
Normal
Normal
Leiom%-oma
Normlal
Normal
Normal
Polv-cvthemia
vera
Relation to
Age Sex 343-T
26 Female Donor
75 Female Paternal
aunt
66 Male Paternal
uncle
60 Female Mlother
52 ' Female Paternal
aunt
9 Female None
45 Female None
538 Female None
I Male None
Materials and methods
Chemicals and en:Ymes
MMLV-RT. random hexonucleotides. guanidinium
isothiocyanate. phenol. chloroform and caesium chloride
were obtained from Life Technologies. Burlington. Ontario.
Canada: [cx- 'S]dATP (1000 Ci mmol-'. 10 mCi ml-') was
obtained from Dupont NEN. Boston. MA. USA: recom-
binant Taq DNA polymerase (AmpliTaq) was obtained from
Perkin Elmer Cetus Corporation. Norw-alk. CT. USA:
Sequenase Recombinant T7 DNA polvmerase (Version 2.0)
was obtained from US Biochemicals. Cleveland. OH.
USA.
Cell strains lines
The GM00038B (GM38) cell strain was obtained from
NIGMS Human Genetic Mutant Cell Repository. Coriell
Institute for Medical Research. Camden. NJ. USA. The BE
and HT-29 cell lines were obtained from Dr T Mulcahy.
Wisconsin Clinical Cancer Centre. Madison. WI. USA.
PreVious publications have described the origin and general
variations of the cell strains from the cancer-prone family
(3437T. 3701T. 3702T. 3703T. 3704T) (Paterson et al.. 1986:
Marshall et al.. 1989). one cell strain from a Li-Fraumeni
family (2800T) and two unrelated donors (GM730A. 3424T)
(Mirzayans et al.. 1995). A brief description of the donors
and their relationship within the cancer prone pedigree is
presented in Table I. The human fibroblast cell strains were
used between passages 15 and 23. All cell strains lines were
maintained as exponentially growing monolaver cultures in
growth medium consisting of alpha-minimal essential
medium (Life Technologies) supplemented with 15% (cell
strains) or 10% (cell lines) fetal bovine serum (Whittaker
Bioproducts. Walkersville. MD, USA. and Sigma. St Louis.
MO. USA) and antibiotics (penicillin and streptomycin): cells
were kept at 37C in a humidified atmosphere of 5% carbon
dioxide and 950o air in 175 cm polystyrene tissue culture
flasks (Nunc. Life Technologies).
Isolation of total RNA
Cells were grown to subconfluence in 175 cm' flasks. the
culture medium was removed. and the cells were washed once
with cold phosphate-buffered saline (PBS) and lysed directly
in the tissue culture flasks with 2.5 ml of guanidimnum
isothiocyanate (4 M) mixture (Sambrook et al.. 1989). The
resulting lysate was then transferred to a polypropylene tube
on ice and the lysate further disrupted by drawing it slowly
through an 18 gauge needle five times. This lysate was
layered over a 5.7.M caesium chloride cushion in Beckman
ultracentrifuge tubes (13 x 51 mm) and centrifuged at
122000g at 20°C for 18h in a Beckman SW55 rotor. The
pellet was resuspended in 400 gil of Tris EDTA SDS solution
and extracted once with phenol-chloroform-isoamyl alcohol
(25:24:1) and once with chloroform-isoamxl alcohol (24:1).
The RNA u-as then precipitated overnight at -'0°C follow-
ing the addition of 0.1 volumes of 2.5 M potassium acetate
(pH 5.0) and two volumes of 100°o isopropyl alcohol. The
precipitates were centrifuged at 1O 000 g at 4°C for 30 mn.
The resulting pellets u-ere washed with 7500 ethanol. recent-
nrfuged briefly. dried at 65°C and resuspended in 100Al of
diethyNlpyrocarbonate (DEPC)-treated water. Concentration
was determined by measuring absorbance at 260 nm. RNA
was stored at - 70C at a concentration of 1 pggpll
Reverse transcription ofRN.4
NQOI and NQO, mRNA Awas transcribed into cDNA for
quantitation and sequencing purposes. Briefly. 7.5 gig of
RNA was added to a 13 gl reaction mixture containing
50 mm Tris-HCI (pH 8.3). 75 mm potassium chloride. 3 mm
magnesium chloride. 10 mm dithiothreitol (DTT). 2 mm
deoxynucleotide triphosphates (Boehringer Mannheim. Mon-
treal. Quebec. Canada). 1Onglgl random hexanucleotides.
40 units gil RNasin (Promega. Madison. WI. USA) and
10 unitspg11 MMLV-RT. This mix was incubated at 37C
for 1 h. terminated by heating to 94°C for 5 min and the
reaction quenched on ice. The resulting cDNA Awas then
immediately amplified using the PCR reaction.
PCR amplification
The cDNA first-strand reactions of NQO, and NQO2 were
used as templates for amplification by PCR in separate reac-
tions. The reaction mixture consisted of 10 gl of cDNA first
strand. 50 mm potassium chloride. 10 mm Tns-HC (pH 8.4).
1.5 mm magnesium chloride. 0.001% gelatin. 0.2mm deoxy-
nucleotide triphosphates. 10 units of AmpliTaq polymerase.
1 gg of each primer (synthesised using an ABI 392 DNA
synthesiser) in a final volume of 100 gil. Mineral oil was
layered on top of the aqueous layer. Tubes were loaded into
a thermal cycler model TC1 or model 480 (Perkin-Elmer
Cetus) at 94°C and 30 cycles of denaturation (94°C. 1 min).
annealing (57C. 1.5 min) and elongation (72°C. 3 min) were
completed. The NQO1 cDNA was amplified using a 5'-NQO,
specific sense oligonucleotide and a 3'-NQO, specific
antisense oligonucleotide (NQOI -SI and NQO1-AS1 respec-
tively). LikeWise. NQO2 cDNA was amplified using
NQO2-S1 5'-specific sense oligonucleotide and NQO2-ASI
3'-specific antisense oligonucleotide. The expected full-length
poly-merase chain reaction (PCR) products of 876 (NQO,)
and 766 (NQO:) nucleotides were obtained. Following
amplification of cDNA the resulting fragments were purified
on a 1% Tris-acetic acid-EDTA agarose gel and extracted
from the agarose using Qiaex beads (Qiagen. Chatsworth.
CA. USA).Base aftrato and DT-dapwase acivity
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DNA sequencing
The entire coding sequence was analysed directly from the
PCR-amplified product using a senres of NQO1-(SI. S2. S3.
ASI. AS2) and NQ02-(S1. S2. ASI) specific
oligonucleotides as sequencing primers by the method of
Winship (1989).
Quantitation ofmRNA
NQOI and NQO2 gene expression was measured in all 11 cell
strains lines by the method of Noonan et al. (1990) with
further modifications. P2m and hydroxymethylbilane synthase
(BDG) mRNA served as endogenous standards to normalise
for amplification quantitation. Product sizes of NQO..
NQO,, BDG and Pm were 313. 253, 120 and 113 nucleotides
respectively. RNA samples (0.8 jg) were reverse transcribed
in a reaction mixture as described above with a total volume
of 16 jIl. The resulting cDNA (16 jil) was combined in a
reaction mixture containing 50 mM potassium chloride,
10 mM Tris-HCI (pH 8.4). 1.5 mm. magnesium chloride,
0.001% gelatin. 0.2 mm deoxynucleotide triphosphates.
4 units of AmpliTaq polymerase and 0.61 iLg of NQO1-FOR,
0.59pg of NQO1-REV, 0.44 jig of NQO2-FOR, 0.87 jig of
NQO2-REV, 0.59;Lg of BDG1 and 0.59 jig of BDG2A or
0.18 jig of PmA3 and 0.23 jg of PmB3 primers in a final
volume of 48 jil. Aliquots of 12 jul were added to each 0.5 ml
tube, overlaid with oil and the tubes were loaded into the
thermocycler, which was preheated to 94'C. Tubes were
removed after 20, 22, 24 and 26 cycles of amplification with
denaturation (94'C. 30 s). annealing (60'C. 30 s) and elonga-
tion (72'C. 60 s) and placed on ice. To analyse each trans-
cription product. 3 jil of gel loading solution (0.25%
bromophenol blue, 0.25% xylene cyanol and 15% Ficoll) was
added to each reaction mixture and the mixture was elect-
rophoresed on a 12% native polyacrylamide gel. Gels were
then stained with ethidium bromide, destained with water
and photographed using Kodak 665 positive-negative film.
The negatives were developed according to the manufac-
turer's instructions. The negatives were then examined using
a laser scanning densitometer (Molecular Dyanamics model
373A) with ImageQuant v3.3 software. In order to ensure
that the NQO,, NQO2, and endogenous standards were
amplified together in the linear amplification range, both Pm
and BDG were used as high and low cDNA expression
standards. respectively. in all reactions. By using both
endogenous standards, cell lines with both high and low
expression of product were comparable. To normalise the
expression of NQO1 and NQO2 to that of the BDG or Pm,
the ratio between the amount of product within the linear
amplification range (previously determined, data not shown)
of the target genes and the endogenous standard was cal-
culated as follows:
R,atio of PCR products
x
volume target gene p,,,
volume internal control gene,pm,,
volume internal control gene,s^ar,
volume target gene,ard,
GM38 was chosen as a standard against which to compare
the remaining cells for NQO1 and NQO2. expression while
BE was the standard for the 345 nucleotide product.
Primers
XQOJ -SI ATGCAAGCTTAATCAGCGCCCCGGACTG
[bases 23-40 of NQO,. with a HindlII restnrction site (under-
lined) 5' adjacent].
NQOI S2 GGAAGCCGCAGACCTTGTGATATFT (bases
326-349 of NQO,).
NQOI-S3 GAAGGCAGTGCTTTCCATCA (bases 473-
492 of NQOI).
VQOI-ASJ CGACGTCGACAAGGAAATCCAGGCTA
AGGA. (bases 879-898 of NQO1. with a Sail restriction site
3' adjacent).
.NQOI-AS2 T-TTGAATTCGGGCGTCTGCT (bases 641-
660 of NQOI).
NQO1-FOR AGAGCACTGATCGTACTGGC (bases 63-
82 of NQOI).
NQOI-REV GTTCAGCCACAATATCTGGG
296-315 of NQO,).
(bases
NQ02-SJ ATGCAAGCTITGGAATCCACCTTICTTACG
(bases 156-173 of the NQO,. with a HindlII restnrction site
5' adjacent.
NQ02-S2 TGCCGGCCATCCTGAAGGGCTGGA (bases
501-524 of NQO2).
NQ02-ASJ CGACGTCGACTGCCCACGTGCCACA
GAG (bases 872-890 of NQO2. with a Sall restriction site 3'
adjacent).
NQ02-FOR AGAGAGACTACGCAGGAAAGC (bases
108-128 of NQO).
NQ02-REV GCCAGAGACCT-TTGCTTGTA (bases 401-
420 of NQO2).
PImA3 ACCCCCACTGAAAAAGATGA (bases 1544-
1563 of Pm).
PnB3 ATCTTCAAACCTCCATGATG (bases 2253-2262
and 3508-3517 of Pm) (Noonan et al.. 1990).
BDGI TGTCTGGTAACGGCAATGCG (bases 29-48 of
BDG).
BDG2A AACGGTGGTGTGACAGGCAGA (bases 128-
148 of BDG).
Exon 6A TCCTCAGAGTGGCATTCTGC.
Exon 6B TCTCCTCATCCTGTACCTCT.
Restriction digestion
Genomic DNA from the lymphocytes of 44 normal individ-
uals was obtained from Dr Mark Minden. Ontanro Cancer
Institute, Toronto. Canada. One microgram of this DNA
was PCR amplified, as previously described, using the follow-
ing touchdown PCR amplification cycles (Don et al., 1994):
2 mmn at 94'C. two cycles of 94'C for 15 s, 69'C for 15 s and
74°C for 30 s; two cycles of 94'C for 15 s. 67'C for 15 s and
74'C for 30 s; 30 cycles of 94'C for 30 s, 65'C for 30 s and
74'C for 60 s using primers specific for NQO, exon 6 (exon
6A and exon 6B). The amplified product was approximately
211 nucleotides in length. Following amplification 10 jil of
the DNA was digested with Hinjl for 1 h at 37'C. The
HinjI-digested product yielded 165 and 46 nucleotide prod-
ucts. The product was then analysed on a 12% native polyac-
rylamide gel. Gels were stained with ethidium bromide, des-
tained with water and photographed.
Enzymatic activity,
Cells were grown to subconfluence before being washed with
PBS and harvested with an 0.25% trypsin (Difco
Laboratories, Detroit. MI, USA) solution in citrate saline.
Cells were pelleted by centrifugation at 240 g for 6mn and
washed twice with PBS and resuspended at 10 cells ml' in
sterile deionised water. Cells were disrupted by three 10-mn
cycles of freeze thawing in dry ice-methanol. Protein concen-
tration was determined using a Total Protein Diagnostic Kit
(Sigma). Reduction of the substrate 2.6-dichlorophenolin-
dophenol (DCPIP) was measured to determine DT-dia-
phorase activity by the method of Benson et al. (1980) with
modifications as previously described (Kuehl et al., 1993).
The activity of P45OR was measured using cytochrome c as
the electron acceptor according to the procedure of Strobel
557
I
IBase rlion and DTahorae aciity
BL KueN et al
558
and Dignam (1978) with modifications as noted previously
(Kuehl et al.. 1993).
Results
Table I demonstrates the clinical status and pedigree relation-
ship of the cell strains obtained from members of a single
cancer-prone family (3437T, 3701T. 3702T. 3703T, 3704T).
Three control cell strains (GM38, GM730A and 3424T)
obtained from three clinically normal volunteers, one non-
related cell strain from a Li-Fraumeni family member
(2800T) as well as two human adenocarcinoma cell lines
HT-29 and BE (Table II) were also examined. Table III
shows the range of DT-diaphorase [reported as dicoumarol
(DIC) inhibited] enzyme activity for these cells. The DT-
diaphorase activity levels of these cell strains,lines differed
over a 200-fold range (18-3462 nmol min- mg-' protein;
Table III). with the BE cell line expressing the lowest activity
and the 3424T cell strain expressing the highest. Cellular
DT-diaphorase activity is measured as a functional assay
(materials and methods). such that the activity reported is
that portion of the activity inhibited by DIC, a reversible and
competitive inhibitor of DT-diaphorase (Halliwell and Gut-
teridge. 1984). It is believed that NQOL and DT-diaphorase
are the same enzyme. although it remains in question if the
assay also measures some low level of NQO2 activity, even
though it is much less active towards the substrate DCPIP
than NQOI (Jaiswal et al., 1990; Jaiswal, 1994). Enzyme
activity is therefore presented as DT-diaphorase activity. The
P450R activity levels only differed over a range of 3-fold
(1-3nmolmin-'mg-' protein, data not shown).
To determine if the present cell strainshlines expressed both
NQO1 and NQO2 mRNAs. and the level of expression of the
transcripts. quantitative reverse transcnption RT-PCR was
performed to obtain predefined product sizes. Table III
shows the levels of NQO, and NQO2 mRNA expression
normalised to the endogenous standards Pm and BDG. and
relative to GM38 or BE levels in the cell strains lines studied.
All of the cell strains lines express both NQO, and NQO.
mRNA. and results for three cell strains lines are shown in
Table 11 Cell onrgin and patient relationship information
Relation to
Cell line Cell origin A4ge Sex 3437T
HT-29 Adenocarcinoma 44 Female None
BE Adenocarcinoma 59 Male None
Figure 1. This technique also revealed the presence of a
larger transcript (approximately 345 nucleotides) in the cells
(Figure 1). This transcript is most prevalent in the BE cell
line which expresses only trace amounts of the NQO2 prod-
uct (Figure 1 and Table III). but can be observed in
moderate levels in the 3437T and 3703T cell strains, and in
trace amounts (<0.2 of BE level) in the remaining cells
(Table III). There does not appear to be any obvious correla-
tion between mRNA expression for NQO, or NQO2 and
DT-diaphorase activity in these cell strains,lines.
Sequencing of the entire NQO, cDNA from all cell strains
lines revealed the presence of a single base change (as
reported by Jaiswal et al.. 1988). from C to G. at base 98 in
the coding region of the NQO1 cDNA. analogous to that
found by Traver et al. (1992). This base change does not
affect the encoded amino acid. Neither the GM38, GM730A,
3424T. 2800T cell strains nor the HT-29 cell line demon-
strated any additional deviations from the reported sequence
(Jaiswal et al.. 1988). The 3437T1 3702T. 3703T and 3704T
cell strains and the BE cell line contained both a C and a T
at nucleotide 609 in the coding region. suggesting that these
cells express both the wild-type and an altered form of NQO,
mRNA. The 3701T cell strain expresses only the T at
nucleotide 609. Figure 2 shows a representative sequencing
gel of nucleotides 600-615 from each cell type (wild-type C.
heterozygous C T, homozygous T). This nucleotide substitu-
tion, which is predicted to change a proline to a senrne
residue, was found even after multiple samples (2-4) were
sequenced indicating that they were not incorporated PCR
errors. The NQO2 cDNA from both the 3437T and the
GM38 cell strains were sequenced and matched the NQO2
coding sequence (Jaiswal et al.. 1990).
The presence of the substituted T at position 609 creates a
Hinfi restriction site (G ANTC). Figure 3 demonstrates the
results of the digestion for three of the human fibroblast cell
strains (GM38, 3437T and 3701T). The figure shows that in
the amplified product no digestion occurs in the absence of
the T (GM38, 211 nucleotide fragment), while partial diges-
tion occurs in the presence of both the C and T (3437T, 211
and 165 nucleotide fragments) and complete digestion occurs
in the presence of the T only (3701T, 165 nucleotide frag-
ment). The 45 nucleotide fragment could not be detected due
to poor resolution of the gel. This restriction site was
exploited to determine if this base substitution at 609 was a
polymorphism present in the population or a mutation car-
ried in this cancer-prone family. Restriction digestion of the
211 nucleotide fragment of NQO, exon 6 (Jaiswal, 1991)
from 44 normal individuals with HinJI revealed that approx-
imately 40% (18 44) of this population express both the C
and T and 9% (4 44) express only the T at this position.
Table III Analysis of the biochemical and molecular charactenrstics of the
expenmental cell strain lines
DT-diaphorase
Cell activitlA
strain (nmolmin mg- ' NQOJ NQO. Nucleotide
line protein) RNAb RNAh 609
3437T 72 12 2.0±0.13 1.3±0.33' CT
3701T 41 8 1.3±0.1 0.95±0.11 T
3702T 863 184 0.82 0.05 1.1 ± 0.16 C T
3703T 1823 104 1.7 0.13 1.1 0.06c C T
3704T 657 139 1.2 0.08 1.1 0.07 C T
GM38 1242 ± 414 1 Cd C
GM730A 2112 ± 738 0.62 0.02 1.1 0.19 C
3424T 3462 ± 201 1.1 0.01 0.81 0.15 C
2800T 1162 406 1.1 0.03 1.2 0.31 C
HT-29 2037 1326 1.4 ± 0.07 0.45 ± 0.04 C
BE 18 10 0.89 0.07 0.13 0.03' CT
'Values shown are mean ± s.d. of at least three independent cell extracts. bValues
shown are mean ± s.e. of three determinations from three independent RT-PCR
reactions. '345 nucleotide product as detected by quantitative RT-PCR. Ratio of
BE NQO, to 345 nucleotide product is 1:0.8. Values relative to BE 345 nucleotide
product: 3437T. 0.49 ± 0.1; 3703T. 0.50 ± 0.08. All others <0.2. dRatio of GM38
NQOI to NQO2 expression is 3:1.Base traton and DT-diahorase actvity
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Figure 1 Representati-e RT-PCR analysis of NQO, and NQO2 mRNA. cycles 20-26. for GM38. BE and 3437T cells. Right
ordinate. product sizes expressed in nucleotides representing 345 (unknown). 313 (NQO). 253 (NQO,) and 113 (pm).
Normal Heterozygous Homozygous
C A T G C A T G C A T G
Figure 2 Autoradiogram of direct sequencing of NQO, cDNA from normal C (GM38). heterozygous (C T (343T) and
homozvgous T (3701T). The arrowhead indicates the altered nucleotide at position 609.
Figure 3 Hinfl digest of GM38. 3437T and 3701T genomic PCR
of NQO, exon 6 fragments. The undigested homozygous C (wild-
type) GM38 fragment is 211 nucleotides. The heterozygous 3437T
fragment digests to yield 211 and 165 nucleotide fragments. The
homozygous T 3701T digest yields only a 165 nucleotide frag-
ment.
Discu
Altered activity levels of DT-diaphorase have been observed
in many different cell strains lines. Recent reports have sug-
gested that the presence of a missense mutation at position
609 (Traver et al.. 1992) and the subsequent loss of
heterozygosity at the NQO, locus (Eickelmann et al.. 1994a)
are responsible for reduced DT-diaphorase activity in an
adenocarcinoma cell line (Traver et al.. 1992) and a bladder
carcinoma cell line (Eickelmann et al., 1994a). To determine
if genetic alterations are involved in DT-diaphorase activity
levels, the current study has further characterised cell strains
from members of a cancer-prone family. as well as three
non-related donors. which have varying DT-diaphorase
activities. The present work, as well as previous work by
others (Marshall et al., 1991; Traver et al., 1992), shows that.
although the DT-diaphorase activity levels differ markedly,
the cell strains'lines examined express similar levels of NQOI
mRNA. These other groups have attempted to detect NQOI
protein by immunoprecipitation and Western blot analysis
using a rat polyclonal antibody against DT-diaphorase and
were able to detect protein in the cells which had high levels
of NQO, activity but not in those cells with extremely low
NQO, activity (3437T, 3701T and BE) (Marshall et al., 1991;
Traver et al.. 1992). Traver et al. (1992) sequenced the NQO,
cDNA in both the BE and HT-29 human colon carcinoma
cell lines and found a C to T base change at nucleotide 609
in the BE cell line and a second base change at nucleotide 98
in both cell lines. The first nucleotide change at position 609
would probably result in the conversion of proline 187 to a
serine while the second base change at nucleotide 98 would
not affect the encoded amino acid. They suggested that the
loss of the proline residue may alter the secondary structure
of the protein, possibly affecting the pyridine binding site of
the enzyme or cause conformational changes around the
cysteine residue. Reduced enzyme activity in this case might
be explained by an altered co-factor binding or other neces-
sary tertiary interactions.
When the cell strainshlines were examined for NQO, and
NQO2 gene expression. it was found that all expressed NQO,
and NQO, mRNA, and that there was no relationship
between the expression of the messages and enzyme activity.
This differs from the work reported by Traver et al. (1992).
which does conclude that a correlation exists between NQO,
mRNA and DT-diaphorase activity in carcinoma cell lines.
The lack of correlation in cell strains may reflect a more
natural system which undergoes ageing-related changes. The
BE cells appear to express only trace amounts of the NQO2
product but express a large amount of a larger 345
nucleotide product (Figure 1 and Table III). The remaining
cells appear to also express this larger product, but in varying
amounts. The 345 nucleotide product appears to be more
prevalent in those cells from the members of the cancer-
prone family as well as in the BE cells. The significance of
this larger product and the low level of the NQO2 product in
BE cells is unknown and further studies are under way in an
attempt to resolve this question.
Similar to the results of Traver et al. (1992). this work also
found a single base change from a C to a G at base 98 in the
coding region of the NQO, cDNA in all of the cell strains
lines examined. This change may represent a population
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polymorphism or, more likely, the originally reported
sequence (Jaiswal et al., 1988) at base 98 is incorrect and the
G is the wild-type nucleotide. A greater number of individ-
uals will need to be examined to verify this observation.
When the cDNA from the cell strains/lines were sequenced
for genetic alterations in the NQO1 gene, it was found that
four of the cell strains from the related members of the
cancer prone family (3437T, 3702T, 3703T, 3704T) as well as
the BE cell line contained both C and T nucleotides at
position 609 of the NQO1 locus (Table III). The 3701T cell
strain appears to be homozygous for the T at nucleotide 609.
In the previous report by Traver et al. (1992) the BE cell line
was also reported to only express a T at nucleotide 609, in
contrast to the present report, in which the BE cell line is
heterozygous at nucleotide 609. One possible explanation for
this discrepancy is that the BE cells previously reported have
either gained a second alteration at this nucleotide or lost
their wild-type allele, although the more likely explanation is
the different PCR amplification and sequencing techniques
employed in the present work and the previous work. Traver
et al. (1992) amplified and sequenced single-stranded as
opposed to double-stranded DNA. This technique may have
selectively amplified the T-containing mRNA over the C-
containing mRNA, and hence the C would not be
observed.
When exon 6 was examined in the genomic DNA of 44
normal individuals it was found that approximately 40%
expressed. both the C and the T while 9% expressed only the
T nucleotide. Previously, it has been reported that 4-10% of
the population lack DT-diaphorase activity (Edwards et al.,
1980; Eickelmann et al., 1994b) and that approximately 11%
of the population have an intermediate level (Edwards et al.,
1980). Several groups have speculated that the T substitution
at nucleotide 609 is responsible for reduced or undetectable
DT-diaphorase activity in human tissue samples (Rovold et
al., 1993; Eickelmann et al., 1994a,b). Eickelmann et al.
(1994a) also demonstrated a lack of measurable DT-
diaphorase activity in three patient kidney carcinoma samples
and in a bladder carcinoma cell line (RT 112MMC), all of
which appear to only express the T at nucleotide position 609
as determined by sequencing analysis and restriction diges-
tion with HinfI. Regardless, the present work suggests that
the function of the substituted nucleotide remains unclear
since a large percentage of the population examined appear
to be heterozygous at this nucleotide and, as seen in Table
III, C/T heterozygotes have widely differing DT-diaphorase
activity. Using the Wilcoxon rank-sum test, the five wild-type
C cell strains also demonstrated a significant difference in
DT-diaphorase activity from the five C/T cell strains at the
0.05 level.
Two models are proposed for the role of the substituted T
nucleotide at position 609. The first model is that the
presence of the T is a polymorphism present in the popula-
tion which has no functional role and no effect on DT-
diaphorase activity. The second model is that the T is a
missense mutation which plays a role in altering DT-
diaphorase activity. Post-transcriptional regulation of DT-
diaphorase activity may occur, such as decreased expression
of the C-containing allele, destabilisation of the mRNA or
the formation of an altered protein. Future work will require
a close examination of both these models to determine how
DT-diaphorase activity is regulated and the impact of this
regulation.
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